STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University School of Medicine — explains to Peter Goodwin how techniques for treating childhood cancers can be used as models for treating adult malignancy, during the 2011 European Multidisciplinary Cancer Congress held in Stockholm where he chaired a session on “Quality of Delivered Cancer Care”.
You may also like...
Which High-Risk Prostate Cancers Need Multimodality Treatment? 18 Apr, 2017 World Malaria Day 2012: Seasonal Prevention: Locals, Like Tourists, Can Be Protected 24 Apr, 2012 Reassurance on Ductal Carcinoma in Situ (DCIS) Treatment De-Escalation 17 Apr, 2018 Genomic-led AML Clinical Decision Making Within Seven Days 31 Dec, 2019
- Previous story Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab
- Next story ASCO 2012 ANNUAL MEETING: Resolving Long Debate, Study Finds Intermittent Hormonal Therapy Less Effective than Continuous Therapy in Certain Men With Advanced Prostate Cancer
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014